Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NEM Formulation Y (#0505) is a specific dietary supplement preparation of Natural Eggshell Membrane (NEM), a proprietary ingredient derived from the thin membrane between the eggshell and the egg white. It is composed of naturally occurring glycosaminoglycans, including chondroitin sulfate and hyaluronic acid, as well as collagen and other beneficial proteins. The formulation was primarily evaluated in clinical trials for its potential to alleviate symptoms of joint and connective tissue disorders, such as osteoarthritis and fibromyalgia. Administered at a 500 mg daily oral dose, NEM Formulation Y is intended to reduce joint pain and stiffness while potentially slowing cartilage degradation. It is developed by ESM Technologies and is marketed as a natural alternative to traditional pharmaceutical treatments for joint health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NEM Formulation Y.